# Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery

> **NCT05398081** · PHASE2 · COMPLETED · sponsor: **Dr. Promise Tamunoipiriala Jaja** · enrollment: 96 (actual)

## Conditions studied

- Surgical Site Infection
- Antibiotics Prophylaxis

## Interventions

- **DRUG:** Cefuroxime (Zinnat®)
- **DRUG:** Ceftriaxone (Rocephin®)

## Key facts

- **NCT ID:** NCT05398081
- **Lead sponsor:** Dr. Promise Tamunoipiriala Jaja
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2022-02-06
- **Final completion:** 2022-03-05
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2023-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05398081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05398081, "Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05398081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*